THE SAFETY OF INTRAVENOUS (IV) FERRIC CARBOXYMALTOSE (FCM) IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD (ND-CKD) : 1-YEAR RESULTS FROM THE FIND-CKD TRIAL